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Objectives: Adverse physiology and antibiotic exposure devastate 
the intestinal microbiome in critical illness. Time and cost implica-
tions limit the immediate clinical potential of microbial sequencing 
to identify or treat intestinal dysbiosis. Here, we examined whether 
metabolic profiling is a feasible method of monitoring intestinal 
dysbiosis in critically ill children.
Design: Prospective multicenter cohort study.
Setting: Three U.K.-based PICUs.
Patients: Mechanically ventilated critically ill (n = 60) and age-
matched healthy children (n = 55).DOI: 10.1097/CCM.0000000000003841
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Interventions: Collection of urine and fecal samples in children 
admitted to the PICU. A single fecal and urine sample was col-
lected in healthy controls.
Measurements and Main Results: Untargeted and targeted met-
abolic profiling using 1H-nuclear magnetic resonance spectros-
copy and liquid chromatography-mass spectrometry or urine and 
fecal samples. This was integrated with analysis of fecal bac-
terial 16S ribosomal RNA profiles and clinical disease severity 
indicators. We observed separation of global urinary and fecal 
metabolic profiles in critically ill compared with healthy children. 
Urinary excretion of mammalian-microbial co-metabolites hip-
purate, 4-cresol sulphate, and formate were reduced in critical 
illness compared with healthy children. Reduced fecal excretion 
of short-chain fatty acids (including butyrate, propionate, and ac-
etate) were observed in the patient cohort, demonstrating that 
these metabolites also distinguished between critical illness and 
health. Dysregulation of intestinal bile metabolism was evidenced 
by increased primary and reduced secondary fecal bile acid ex-
cretion. Fecal butyrate correlated with days free of intensive care 
at 30 days (r = 0.38; p = 0.03), while urinary formate correlated 
inversely with vasopressor requirement (r = –0.2; p = 0.037).
Conclusions: Disruption to the functional activity of the intestinal 
microbiome may result in worsening organ failure in the critically ill 
child. Profiling of bacterial metabolites in fecal and urine samples 
may support identification and treatment of intestinal dysbiosis in 
critical illness. (Crit Care Med 2019; XX:00–00)
Key Words: 16S ribosomal ribonucleic acid gene sequencing; 
critical illness; critically ill child; gut health; intestinal microbiome; 
metabolomics
There has been a surge of interest in the contribution of the gut microbiome to health and disease. Bacteria residing in the intestinal tract are, in health, compart-
mented from the host but have a symbiotic relationship, con-
tributing to metabolic, endocrine, and immune functions.
The composition and diversity of the intestinal microbi-
ome in critical illness is likely to be impacted by poor intestinal 
perfusion, hypoxia, lack of enteral feeds, and antimicrobial 
therapy (1–4). This creates opportunities for the proliferation 
of potentially pathogenic species associated with adverse out-
comes, including secondary infection and mortality (5–9).
Profiling of the intestinal microbiome has generally been 
undertaken through sequencing of microbial DNA. However, 
more detailed functional information about the intestinal 
microbiome is possible through capture of metabolic outputs. 
1H-nuclear magnetic resonance (1H-NMR) spectroscopy and 
mass spectrometry (MS) allow simultaneous detection of both 
human and microbial metabolites within biological samples. 
This may offer an insight into host-microbe interactions in the 
complex human system. Furthermore, such methods could 
provide a more cost-effective approach to understanding the 
clinical impact of intestinal dysbiosis in critical illness.
We previously identified significant plasma metabolic 
signatures of critical illness and organ failure in critically ill 
children (10). In the current study, we set out to characterize 
the functional capacity of the intestinal microbiome in critical 
illness, through multi-compartmental metabolic profiling. We 
examined changes in bacterial and host metabolites in urine 
and feces in order to characterize the gut microbiota-host rela-
tionship in severe illness.
MATERIALS AND METHODS
Study Population
Critically ill children between 1 and 16 years old were consec-
utively enrolled at the time of admission to the PICU if they 
were mechanically ventilated and an admission urine sample 
was available within 48 hours of PICU admission. Children 
who were on chronic steroid or immune suppressant treat-
ment were excluded. Data were obtained from the clinical 
health records. Healthy children, recruited from the local com-
munity, were eligible if they were well, had a normal healthy 
diet, and had not received antibiotics in the prior 3 months.
Approval for the study was granted by the East Midlands-
Nottingham 2 Research Ethics Committee for recruitment from 
the PICUs at Cambridge University Hospitals NHS Foundation 
Trust, Great Ormond Street Hospital NHS Foundation Trust, and 
Imperial College Healthcare NHS Foundation Trust and from the 
City Road and Hampstead Research Ethics committee for recruit-
ment of healthy children in the Cambridge vicinity. Parental in-
formed consent was obtained prior to participation in the study.
Samples
Urine samples were collected via indwelling catheters as soon 
as possible after admission to PICU (timepoint 1). Further 
samples were obtained at day 3–5 and days 6–8 (timepoint 2 
and timepoint 3, respectively) after admission. Urine samples 
from healthy children were collected directly into 20 mL uni-
versal containers and stored at –70°C until use.
Fecal samples were collected from early (within first 2 d 
of PICU admission) and late (days 5–8 of PICU admission) 
in critically ill children, and a single sample obtained from 
healthy children. Samples were collected from nappies, placed 
in sterile plastic containers and stored at –70°C until use.
Clinical Data Acquisition
Disease severity was defined through collation of bedside phys-
iologic data. In addition, routinely collected clinical data were 
recorded for multivariable analysis to identify associations 
with cardiovascular failure (the maximal inotrope score [11]), 
respiratory failure (days free of mechanical ventilation at 30 d), 
and critical illness duration (days free of PICU at 30 d).
1H-NMR Spectroscopy
Fecal water and urine samples were prepared for 1H-NMR 
Spectroscopy according to published protocols (12). Acquired 
spectroscopic data were processed using the TopSpin 3.1 soft-
ware package (Bruker Biospin, Rheinstetten, Germany). Data 
processing was undertaken using Matlab (Version 8.3.0.532 
R2014a; Mathworks, Natick, MA). Further details are given 
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in supplemental methods (Supplemental Digital Content 1, 
http://links.lww.com/CCM/E693).
Chemometric Analysis of Spectroscopic Data
Processed spectroscopic data were imported to the SIMCA 13.0 
software package (Umetrics AB, Umeå, Sweden) to conduct un-
supervised multivariate statistical analysis. Principal components 
analysis was used to evaluate similarities/differences in urinary 
and fecal metabolite composition between groups. The R2 and 
Q2 variables provided an indication of goodness of fit (R2) as 
well as goodness of prediction (Q2) of the models. Supervised 
Orthogonal Projections to Latent Structures Discriminant Anal-
ysis models were calculated using one predictive and two orthog-
onal components. The models were assessed based on variance 
explained (R2Y) and predictive ability (Q2Y) metrics. Further 
details are given in the supplemental methods (Supplemental 
Digital Content 1, http://links.lww.com/CCM/E693).
Bile Acid Quantification
Bile acid data were acquired using an liquid chromatography-
mass spectrometry quadrupole time-of-flight instrument in 
profiling mode, according to protocols described by Sarafian 
et al (13). The identity of the bile acids was confirmed by com-
parison of their retention times and mass spectra with those of 
reference standards also included in the analytical run.
Fecal DNA Extraction and Bacterial 16S Ribosomal 
RNA Gene Sequencing
Whole microbial genome DNA was extracted from fecal sam-
ples using PowerFecal DNA Isolation Kit (MO BIO Laborato-
ries, CA). Aliquots of extracted genomic DNA were quantified 
using Qubit dsDNA HS Assay Kit (Life Technologies, MA). The 
DNA was amplified with Illumina adapter and indexed poly-
merase chain reaction primers. Bacterial 16S ribosomal RNA 
was sequenced using the Illumina MiSeq sequencing platform 
(Illumina, Inc., San Diego, CA) as previously described (14). 
Further details are given in the supplemental methods (Supple-
mental Digital Content 1, http://links.lww.com/CCM/E693).
Bioinformatic and Statistical Analysis for Bacterial 
16S Sequence Data
Multivariate diversity analysis between patient and control 
samples was performed using PERmutational Multivariate 
ANalysis Of VAriance (PERMANOVA) using the Adonis func-
tion from the R package VEGAN (15).
Rank-based indirect gradient analysis “nonmetric multi-
dimensional scaling (NMDS)” was used for the visualization 
of taxonomic differences between the different groups, using 
metMDS in R (15, 16). NMDS attempts to represent, as closely 
as possible, the pairwise dissimilarity between objects in a 
low-dimensional space. Further details are given in the supple-
mental methods (Supplemental Digital Content 1, http://links.
lww.com/CCM/E693).
Statistical Analysis
Multiple linear and logistic regression analyses were applied 
using the Statistical Package for the Social Sciences Version 
21 (SPSS Statistics 22, IBM Corp., Armonk, NY). Categorical 
variables were analyzed using chi-square and Fisher exact tests 
as appropriate. Continuous variables were compared using 
two-sided t tests (for parametric variables) and the Mann-
Whitney U test (nonparametric variables). A false discovery 
rate (FDR) was used to adjust for multiple metabolite testing. 
Metabolites with FDR less than 0.05 were considered significant.
Multivariate beta diversity analysis between groups, including 
age, gender, and diagnostic category, was performed using R studio 
and the Statistical Package for the Social Sciences (SPSS Statistics 
22, IBM Corp.). All presented p values were corrected for multiple 
comparisons using the Benjamini-Hochberg FDR method.
RESULTS
Participant Demographics
The mean (sd) ages and weights were 70.28 months (52.8 mo) 
and 21.5 kg (13.5 kg) for patients; 73.5 months (43.7 mo) and 
20.9 kg (10.1–41 kg) for controls. Four children died in the pa-
tient cohort (5.9%). All the critically ill children had received one 
or more broad-spectrum antibiotics at the time of sampling. Fur-
ther clinical details and antibiotic exposure are given in Table 1.
Urinary Metabolic Profiling Demonstrates Loss of 
Intestinal Bacterial Metabolic Activity in Critical 
Illness
We identified robust differences in the global 1H-NMR met-
abolic profiles of admission (timepoint 1) urine samples 
from critically ill compared with healthy children (Fig. 1A), 
TABLE 1. Clinical Details of Study Participants
Primary Organ Failurea Number of Patients %
Cardiac 2 2.94
Neurological 15 22.06
Respiratory 25 36.76
Sepsis 18 26.47
Trauma/surgical 8 11.76
Total 68 100
Antibiotic Therapyb Number of Patients %
Meropenem 1 1.47
Cephalosporin 45 66.18
Penicillin 15 22.06
Tazobactam 6 8.82
Macrolide 22 32.35
Metronidazole 7 10.29
Aminoglycoside 8 11.76
Clindamycin 5 7.35
aPrimary organ failure indicates the main cause of PICU admission.
bThe type of antibiotic class administered at the time of first urine and fecal 
sampling is indicated by the number of children receiving each antibiotic type. 
Many children were exposed to more than one class at the time of sampling.
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indicating differences in both endogenous and intestinal 
microbiome-derived metabolites. Using supervised multivar-
iate statistical analysis, we observed R2Y and Q2Y values of the 
generated model at 0.89 and 0.8, respectively (Fig. 1B).
Urinary excretion of several mammalian-microbial co-
metabolites were reduced in critically ill patient samples 
(Supplementary Table 1, Supplemental Digital Content 2, 
http://links.lww.com/CCM/E694). These included hippurate, 
4-cresol sulphate, and formate. In addition, two bile acid peaks 
were associated with samples from the patient cohort, and a 
strong reduction in urinary citrate excretion observed in sam-
ples from critically ill compared with healthy children.
We did not observe a strong separation in the global urine met-
abolic profile based on sample timing during the course of PICU 
stay (Supplementary Fig. 1, a and b, Supplemental Digital Content 
3, http://links.lww.com/CCM/E695; legend, Supplemental Digital 
Content 9, http://links.lww.com/CCM/E701). There was no dif-
ference in global metabolic profiles based on gender, comorbidity 
status, duration or class of antibiotic exposure, and survival.
Untargeted Fecal Metabolic Profiling Indicates Loss 
of Bacterial Fermentation Activity in Critical Illness
As with urinary metabolic profiles, the global 1H-NMR met-
abolic profiles of fecal water in critically ill compared with 
healthy children were strongly separated (Fig. 1C). Using 
supervised multivariate statistical analysis, we observed R2Y 
and Q2Y values of the generated model at 0.7 and 0.17, respec-
tively (Fig. 1D). Metabolites showing discrimination between 
critically ill and healthy samples included short-chain fatty 
acid (SCFA) concentrations (among them butyrate, acetate, 
and propionate) and the nucleobase thymine which associated 
with healthy child sample profiles. Lactate and N-acetylgly-
coprotein associated with samples from critically ill children 
(Supplementary Table 2, Supplemental Digital Content 4, 
http://links.lww.com/CCM/E696).
As with the urine, we did not identify differences based on 
gender, comorbidities, duration or class of antibiotic exposure, 
and survival status.
Figure 1. Urinary and fecal 1H-nuclear magnetic resonance (1H-NMR) global metabolic profiles of critically ill and healthy children. A, Unsupervised 
principal components analysis (PCA) scores plot of admission urine samples from age-matched critically ill (red) and healthy (blue) children. R2 = 0.16,  
Q2 = 0.09. B, Supervised Orthogonal Projections to Latent Structures Discriminant Analysis (O-PLS-DA) loadings line plot. Urinary metabolites higher 
in critically ill children (up) compared with age-matched healthy children (down). The color bar indicates the correlation coefficient (R2) (i.e., the 
redder the peak, the higher the correlation). R2Y = 0.89, Q2Y = 0.80. C, Unsupervised PCA scores plot of fecal samples from age-matched critically ill 
(red, n = 27) and healthy control (blue, n = 41) samples. R2 = 0.23, Q2 = 0.08. D, Supervised O-PLS-DA loadings line plot. Fecal metabolites higher 
in critically ill children (up) compared with age-matched healthy children (down). R2Y = 0.96, Q2Y = 0.85. R2Y = variance explained, Q2Y= predictive 
ability. a.u = arbitrary units, N-AG = n-acetylglucosamine, NMNA = n-nethylnicotinamide.
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Intestinal Bacterial Metabolism of Bile Acids Is 
Compromised During Critical Illness
Based on the presence of increased urinary bile acid concen-
trations in patient urine samples, we went on to examine in-
testinal bile acid metabolism using targeted MS. We observed 
clear separation in overall fecal bile acid profile between criti-
cally ill and healthy children (Fig. 2A), with observed R2Y and 
Q2Y values of the generated model at 0.47 and 0.27, respec-
tively (Supplementary Fig. 2, Supplemental Digital Content 5, 
http://links.lww.com/CCM/E697; legend, Supplemental Dig-
ital Content 9, http://links.lww.com/CCM/E701).
In samples from critically ill children, a statistical increase in 
primary bile acid concentrations (cholic and choledeoxycholic 
acids) was observed. A reduction in concentration of secondary 
bile acids dependent on commensal bacterial metabolism was 
observed, including deoxycholic and lithocholic acids along 
with other bile acid metabolites arising from bacterial dehy-
droxylation, epimerization, or oxidation (Fig. 2B).
Loss of Intestinal Metabolic Capacity Is Associated 
With Intestinal Dysbiosis in the Critically Ill Child
Using the Shannon alpha diversity index as an indicator of 
fecal microbial diversity, we observed mean (sd) alpha diver-
sity at genus level of 2.82 (0.34) compared with 2.12 (0.87) in 
samples from healthy versus critically ill children, respectively 
(p < 0.0001).
NMDS demonstrated greater inter-individual variability in 
patient 16S profiles compared with those of healthy children 
(Fig. 3). Hierarchical analysis demonstrated that healthy chil-
dren had higher prevalence of Bacteroides, Faecalibacterium, 
and Ruminococcus genera. Samples from critically ill chil-
dren showed increased presence of noncommensals (e.g., 
Enterococcus and Streptococcus), and of normally low-
prevalence microbial genera 
(Supplementary Fig. 3, 
Supplemental Digital Content 
6, http://links.lww.com/CCM/
E698; legend, Supplemental 
Digital Content 9, http://links.
lww.com/CCM/E701).
We did not observe any 
statistical difference in the 
overall fecal microbial profile 
based on specific antibiotic 
class exposure or the days of 
antibiotic exposure prior to 
sampling. However, that the 
proportional abundance of the 
Enterococcus genus in patient 
samples directly correlated 
with the number of antibiotic 
classes administered prior to 
sample collection (r = 0.43; 
p = 3 × 10–6).
Patterns of Change 
in Composition and 
Function of the Intestinal 
Microbiome in Critical 
Illness
We undertook integrated anal-
ysis of fecal microbial 16S, and 
metabolic profiles using re-
gression analysis and unsuper-
vised clustering. Metabolites 
associated with samples from 
healthy children included ace-
tate, propionate, and butyrate. 
An inverse correlation was 
noted of fecal SCFA levels with 
proportional abundance of 
Enterococcus, Bifidobacteria, 
Figure 2. Fecal liquid chromatography-mass spectrometry bile acid (BA) profiles of critically ill and healthy 
children. A, Unsupervised principal components analysis scores plot of critically ill (red) and healthy control 
(blue) samples. R2 = 0.47, Q2 = 0.16. B, Changes in the metabolism of BAs in critically ill (in red) compared 
with healthy children (in blue) illustrate accumulation of primary BAs and a reduction in lithocholic acid in 
critically ill children. 5β-CA-3β, 12a-diol = 5β-cholanic acid-3β, 12a-diol, FDR 2.952E-6, 23 nor 5β- CA-3α, 
12a-diol = 23-nor-5b-cholanic acid-3a, 12a-diol, FDR 1.664E-7, 3KCA = 3 ketocholanic acid, FDR 3.505E-
7, 3a-H-12 KLCA = 3a-hydroxy-12 ketolithocholic acid, FDR 4.174E-6, CA = cholic acid, FDR 2.142E-7, 
DCA = deoxycholic acid, FDR 0.004, FDR = false discovery rate, ILCA = isolithocholic acid, FDR 1.596E-10, 
LCA = lithocholic acid, FDR 6.157E-10, PC = principal component, TCA = taurocholic acid, FDR 0.001.
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Escherichia-Shigella, and Staphylococcus genera (Supplemen-
tary Table 1, Supplemental Digital Content 2, http://links.lww.
com/CCM/E694). Linear regression demonstrated that abun-
dance of Faecalibacterium, Fusicatenibacter, and Phascolarcto-
bacterium were most predictive of fecal butyrate levels (R2 = 0.32; 
F = 9.44; p < 0.0001).
We observed that intermediate metabolites of the citric acid 
cycle including fecal succinate, lactic acid, oxaloacetic acid, py-
ruvic, and acetoacetic acid were associated with the 16S profiles 
of critically ill compared with healthy children (Supplementary 
Fig. 4a, Supplemental Digital Content 7, http://links.lww.com/
CCM/E699; legend, Supplemental Digital Content 9, http://
links.lww.com/CCM/E701).
We examined the association between fecal microbial com-
position and bile acid secretion in the patient cohort. We noted 
an inverse correlation between alpha diversity with primary 
bile acids including taurocholic acid (r = –0.44; p = 0.023) and 
taurohyocholic acid (r = –0.55; p = 0.003), and a direct cor-
relation with secondary bile acids lithocholic acid (r = –0.48; 
p = 0.011) and isolithocholic acid (r = –0.6; p = 0.0001).
Bacterial genera including Bacteroides, Ruminococcus, 
Eubacterium, Lachnospiraceae, and Faecalibacterium were di-
rectly correlated with levels of secondary bile acids including 
deoxycholic, lithocholic, and isolithocholic acid. Conversely, 
these bile acids were negatively correlated with abundance of 
Enterococcus and Staphylococcus (Supplementary Table 3, 
Supplemental Digital Content 8, http://links.lww.com/CCM/
E700).
In a linear regression model, we observed that pro-
portional abundance of Faecalibacterium, Coprococcus, 
Ruminococcus, Catabacter, Enterococcus, Oscillibacter, and 
Pseudobutyrivibrio genera were predictive of fecal lithocholic 
acid concentration (R2 = 0.27; F = 2.34; p = 0.032).
Metabolic Markers of Disease Severity in Critical 
Illness
The peak integral values for fecal butyrate in the early admis-
sion samples of critically ill children correlated directly with 
days free of intensive care at 30 days (r = 0.38; p = 0.03). Peak 
integral values for urinary formate were inversely correlated 
with vasopressor requirement as measured by the inotrope 
score (17) (r = –0.2; p = 0.037). Urinary citrate directly cor-
related with inotrope score in patient samples (r = –0.27; 
p = 0.004).
DISCUSSION
Although the adverse effects of critical illness on the composi-
tion of the intestinal microbiome in adults and children have 
been reported (5, 6, 9), the functional consequences of this 
on the developing pediatric microbiome have not been well 
described. We identified several changes in intestinal micro-
bial activity during critical illness, including the fermentation 
of terminal carbohydrate metabolites into SCFAs and bile acid 
metabolism.
Undigested carbohydrate and protein are key substrates for 
fermentation by colonic microbiota, and the resulting metab-
olites include SCFAs, branched-chain fatty acids, ammonia, 
amines, phenolic compounds, and gases including hydrogen, 
methane, and hydrogen sulphide. A healthy trophic network of 
SCFAs is maintained by a diverse number of commensal spe-
cies in the gut (18, 19). The three main SCFAs, acetate, propi-
onate, and butyrate are used in a number of host metabolic 
processes including signaling effector roles to modulate distal 
organ function (20), and in maintaining the health and barrier 
function of the colonic mucosa (21).
Sustained reduction in fecal levels of SCFAs compared with 
healthy controls has been previously documented in critically 
ill adults (3).
Commensal microbes regulate bile acid metabolism in the 
lower intestine (22) and are involved in deconjugation and 
dehydroxylation of bile acids released by the gall bladder into 
the intestinal lumen (23). Ours is the first study to demonstrate 
dysregulation of fecal bile acid metabolism in pediatric critical 
illness. Our data fits with previous observations of reduced lu-
minal SCFA and secondary bile acid concentrations in murine 
microbiome depletion models (24, 25).
The patient microbiome was characterized by over-repre-
sentation of opportunistic pathogenic species and with species 
typically associated with the small intestine or with the use of 
Figure 3. Bacterial composition in age-matched critically ill and healthy 
children. Nonmetric multidimensional scaling (NMDS) plot of fecal 
microbial composition at genus level. High variability is seen in samples 
from critically ill children (red) compared with healthy controls (orange). 
PERmutational Multivariate ANalysis Of Variance (PERMANOVA) p = 
0.0001, F = 3.314. Samples from healthy children were tightly clustered 
together, suggesting greater similarity in composition, while those from 
patients were scattered widely across the plot and statistically separated 
from the healthy profiles (PERMANOVA test: F = 9.78; p < 0.001).
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antibiotics in critical illness including (Enterococcus) (6, 26) or 
with diarrhea (Streptococcus) (27).
We were surprised not to see any microbial or metabolic 
patterns of change over the course of PICU admission, given 
the dynamic physiology of critical illness. However, it is likely 
that the ongoing exposure to systemic antibiotics is likely to 
influence the rate of recovery of intestinal microbial activity 
in this population. In critically ill adults, the fecal microbiome 
appears to continue to show significant dysbiosis at the time of 
ICU discharge (29). Our patient samples were collected at or 
within the first few days of PICU admission, so there was little 
variance in duration of antibiotic exposure.
Broad-spectrum antibiotics are frequently administered to 
treat suspected infection in children and adults with critical 
illness (6, 28). Often it is done for life-saving reasons. The fact 
that all patients in our study received broad-spectrum antibi-
otics is a limitation, and future studies should include samples 
from nonantibiotic exposed children.
Our finding that the number of antibiotic classes admin-
istered was associated with proportional abundance of the 
Enterococcus genus is in keeping with studies in critically ill 
adults (30). The most comparable study in critically ill chil-
dren (6) did not explore the issue of antibiotic class in detail, 
although as in our study, administration of antibiotics was 
widespread (89% of a population where 94% were mechani-
cally ventilated).
We were surprised not to find a differentiation in 16S or 
metabolic profiles between patients with and without preex-
isting comorbidity. It suggests that the combination of adverse 
exposures in critical illness is greater than the impact of preex-
isting illness. Although there have been studies of the microbi-
ome in patients with a protracted course of critical illness (26), 
we did not identify any studies that compared ICU admission 
microbiome profiles in previously well individuals compared 
with those living with life-long conditions.
We saw no significant impact of gender on the composition 
of the microbiome in our patient cohort, which was not unex-
pected given that the majority of children in the study were pre-
pubertal. Studies in healthy neonates have not demonstrated 
gender-based differences in the neonatal urinary metabolome 
(31), and in older healthy children, population-specific factors 
(age, sex, body mass index, ethnicity, dietary, and country of 
origin) appear to be better captured in serum than in urine 
metabolic profiles (32). We did not find any published data of 
gender-based differences in critically ill children or adults. In a 
cohort study of 43 newborns over 2 years, the most significant 
influences on fecal microbiome maturation were birth mode, 
antibiotic exposure, and diet (33).
Our integrated analysis reflects the accumulation of inter-
mediate fermentation metabolites in critical illness as a result 
of intestinal dysbiosis (Supplementary Fig. 4b, Supplemental 
Digital Content 7, http://links.lww.com/CCM/E699; legend, 
Supplemental Digital Content 9, http://links.lww.com/CCM/
E701). The gross decline of Bacteroides, Faecalibacterium, 
Roseburia, and Prevotella and their associations with the pro-
duction of acetate, butyrate, and propionate substantiate this.
We did not observe any microbial or metabolic signatures 
of nonsurvival, although our study was not powered for this 
outcome. In adults, pathogen colonization of the fecal micro-
biome has been shown to be associated with death (9).
Fecal SCFA measurement has been shown to be an effective 
tool to monitor recovery of gut microbiome in neonatal and 
murine probiotic supplementation trials (34, 35). The ability 
to assess the intestinal microbiome using urine metabolic pro-
filing is advantageous in this patient population, since fecal 
samples may not be available acutely. The methodology to un-
dertake the metabolite assays is scaleable and could be used 
to monitor gut health during and after recovery from critical 
illness.
We have demonstrated that profiling of bacterial metabo-
lites offers an insight into the functional capacity of the intes-
tinal microbiome. A reduced abundance of these metabolites is 
linked to clinical disease severity.
Dietary and microbiome-based therapies are being explored 
for the potential to support recovery of healthy gut commensal 
populations during and after critical illness. The panel of bac-
terial metabolites we have identified could be used to stratify 
and monitor such interventions. Beyond critical illness, the 
methodology is applicable to other disorders such as inflam-
matory bowel disease or severe malnutrition. The technology 
is scalable and adapting it to a clinically relevant format is 
feasible.
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